Skip to main content

Cody Regional Health: Medication Monitoring Failures - WY

Cody Regional Health: Medication Monitoring Failures - WY
Healthcare Facility
Cody Regional Health Long Term Care Center
Cody, WY  ·  4/5 stars

Federal inspectors found that Cody Regional Health Long Term Care Center failed to establish target symptoms for antipsychotics and antidepressants prescribed to residents, making it impossible to determine if the medications helped or harmed patients.

The violation affected multiple residents receiving psychotropic drugs for conditions including non-Alzheimer's dementia, depression, and bipolar disorder.

Advertisement
Advertisement

One resident with short-term and long-term memory impairment received three psychiatric medications daily. The person took bupropion 150 mg for major depressive disorder, fluoxetine 20 mg for bipolar disorder, and olanzapine 5 mg at bedtime for bipolar disorder.

Care plans for the antidepressant and antipsychotic medications included only generic instructions to "monitor for side effects and effectiveness." But medical records contained no specific target symptoms that would allow staff to measure whether the drugs actually improved the resident's condition.

Another resident received lorazepam, a powerful anti-anxiety medication that can cause confusion and falls in elderly patients. Again, medical records showed no medication-specific target symptoms identified for the drug.

The facility's own policy defined unnecessary drugs as medications used "without adequate monitoring." Yet staff couldn't explain what they were monitoring for when inspectors interviewed them on April 9.

The director of nursing, staff development coordinator, social services director, licensed practical nurse, and pharmacist all confirmed during a group interview that the facility did not identify or monitor resident-specific or medication-specific target symptoms for psychotropic medications.

Without target symptoms, nursing staff had no way to determine if psychiatric medications were helping residents or causing harmful side effects. They couldn't measure whether a resident's anxiety decreased, depression improved, or behavioral symptoms changed after starting treatment.

The monitoring failure is particularly concerning for elderly residents with dementia, who face heightened risks from psychiatric medications. Antipsychotics can increase the risk of stroke and death in dementia patients, while multiple antidepressants can interact dangerously or cause excessive sedation.

Federal regulations require nursing homes to ensure residents receive only necessary medications and to monitor their effectiveness. The lack of target symptoms makes it impossible to meet either requirement.

Resident #5's case illustrated the problem clearly. Despite receiving three psychiatric medications for documented mental health conditions, staff had no specific symptoms they were tracking to determine if the drugs helped with depression, stabilized bipolar episodes, or reduced behavioral issues.

The care plans last revised in May 2025 contained identical language for both antidepressant and antipsychotic monitoring, suggesting a template approach rather than individualized assessment of each resident's needs.

Psychotropic medications require careful monitoring in nursing home residents because of their potential for serious side effects, drug interactions, and reduced effectiveness over time. Without identifying specific target symptoms, staff cannot distinguish between medication benefits and natural fluctuations in a resident's condition.

The inspection found that this systematic monitoring failure affected the facility's entire approach to psychiatric medication management. Staff lacked the basic information needed to advocate for residents who might benefit from medication adjustments or discontinuation.

Inspectors classified the violation as causing minimal harm or potential for actual harm to some residents. However, the inability to properly monitor powerful psychiatric medications in vulnerable elderly residents with cognitive impairment represents a fundamental breakdown in medication safety protocols.

The facility's own pharmacist participated in the interview confirming the monitoring deficiencies, indicating the problem extended beyond nursing staff to the professional oversight of the medication program.

Full Inspection Report

The details above represent a summary of key findings. View the complete inspection report for Cody Regional Health Long Term Care Center from 2026-04-09 including all violations, facility responses, and corrective action plans.

Additional Resources


Editorial Standards

Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).

Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.

Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.

Last verified: June 13, 2026  ·  Our methodology

Quick Answer

Cody Regional Health Long Term Care Center in Cody, WY was cited for violations during a health inspection on April 9, 2026.

The violation affected multiple residents receiving psychotropic drugs for conditions including non-Alzheimer's dementia, depression, and bipolar disorder.

Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.

Frequently Asked Questions

What happened at Cody Regional Health Long Term Care Center?
The violation affected multiple residents receiving psychotropic drugs for conditions including non-Alzheimer's dementia, depression, and bipolar disorder.
How serious are these violations?
Violation severity varies from minor documentation issues to serious safety concerns. Review the inspection report for specific deficiency codes and scope. All violations must be corrected within required timeframes and are subject to follow-up verification inspections.
What should families do?
Families should: (1) Ask facility administration about specific corrective actions taken, (2) Request to see the follow-up inspection report verifying corrections, (3) Check if this represents a pattern by reviewing prior inspection reports, (4) Compare this facility's ratings with other nursing homes in Cody, WY, (5) Report any new concerns directly to state authorities.
Where can I see the full inspection report?
The complete inspection report is available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request a copy directly from Cody Regional Health Long Term Care Center or from the state Department of Health. The report includes specific deficiency codes, facility responses, and correction timelines. This facility's federal provider number is 535027.
Has this facility had violations before?
To check Cody Regional Health Long Term Care Center's history, visit Medicare.gov's Care Compare and review their inspection history, quality ratings, and staffing levels. Look for patterns of repeated violations, especially in critical areas like abuse prevention, medication management, infection control, and resident safety.


Advertisement